Neonatal Hypoglycemia: Cortisol 1.9 + Insulin 11 - Interpretation & Approach

Interpreting the "Critical Sample"

The Key Differential Diagnoses

1. Hypopituitarism (Most Likely Combined Picture)

• ACTH deficiency → adrenal cortex not stimulated → low cortisol
• Growth hormone deficiency → loss of counter-regulatory response, and GH normally suppresses insulin action
• The "elevated" insulin of 11 is actually relatively mild - in the context of pituitary deficiency, insulin sensitivity is increased and even modest insulin levels cause profound hypoglycemia

• Midline defects (septo-optic dysplasia, cleft palate, single central incisor)
• Micropenis / undescended testes in males (LH/FSH deficiency)
• Nystagmus (optic nerve hypoplasia)
• Jaundice (may be prolonged in hypopituitarism)

2. Primary Adrenal Insufficiency

• Cortisol 1.9 is clearly low (normal stress response requires >18 µg/dL)
• Causes in neonates: congenital adrenal hyperplasia (CAH), adrenal hypoplasia congenita (DAX-1/NR0B1 mutation), adrenal hemorrhage, familial glucocorticoid deficiency
• CAH (21-hydroxylase deficiency) can also cause salt-wasting crisis - check electrolytes for hyponatremia + hyperkalemia
• The elevated insulin in isolated adrenal insufficiency is less well explained and suggests either a co-existing issue or hypopituitarism

3. Hyperinsulinism (Congenital)

• Insulin >2 µIU/mL during hypoglycemia is abnormal and raises concern for hyperinsulinism
• A glucose requirement >8 mg/kg/min to maintain normoglycemia is characteristic
• Congenital hyperinsulinism (CHI) is the most common cause of persistent neonatal hypoglycemia beyond the first week of life
• Can be caused by mutations in ABCC8 (SUR1), KCNJ11 (Kir6.2), GCK, GLUD1, and others
• The low cortisol here could be secondary (pituitary) or a stress response failure rather than isolated CHI

Additional Workup Needed

1. Growth hormone (low in hypopituitarism; should rise during hypoglycemia)
2. Free fatty acids (low in hyperinsulinism - insulin suppresses lipolysis; expected <1.5 mmol/L)
3. Beta-hydroxybutyrate (low in hyperinsulinism - expected <2 mmol/L)
4. Glucagon stimulation test: A rise in glucose ≥30 mg/dL confirms glycogen stores are intact and insulin is inappropriately holding glucose in cells
5. 17-OHP (to exclude CAH)
6. Electrolytes (hyponatremia/hyperkalemia in adrenal crisis)
7. Brain MRI - look for optic nerve hypoplasia, absent septum pellucidum (septo-optic dysplasia), pituitary abnormalities
8. ACTH stimulation test (once stable) to formally assess adrenal axis
9. Genetic panel for CHI (ABCC8/KCNJ11 mutations guide surgical vs. medical management)

Immediate Management

1. Secure IV access and give IV dextrose (D10W 2 mL/kg bolus, then continuous infusion) to maintain glucose >70 mg/dL
2. If adrenal insufficiency is confirmed or strongly suspected: hydrocortisone 1-2 mg/kg IV (also helps mobilize glucose via gluconeogenesis)
3. If hyperinsulinism confirmed: diazoxide (first-line oral agent, 5-15 mg/kg/day) - keeps beta-cell K-ATP channels open, suppressing insulin secretion. Note: carries a black box warning for pulmonary hypertension in neonates
4. If diazoxide-unresponsive: octreotide (somatostatin analogue) or glucagon infusion
5. Persistent/focal CHI may require near-total pancreatectomy after PET scan with 18F-DOPA to localize focal disease

Summary Diagnostic Framework

Neonatal hypoglycemia
   ├── Cortisol LOW (1.9) → Adrenal/pituitary insufficiency
   │     ├── + Low GH → Hypopituitarism (check midline defects, MRI brain)
   │     └── + Normal GH, high ACTH → Primary adrenal insufficiency (CAH, adrenal hypoplasia)
   └── Insulin HIGH (11) → Hyperinsulinism
         ├── + Low cortisol → Hypopituitarism (GH/ACTH deficiency)
         ├── Genetic CHI (KATP channel mutations)
         └── Transient (IDM, perinatal stress, IUGR, Beckwith-Wiedemann)